Olema Pharmaceuticals Inc reports results for the quarter ended in March - Earnings Summary

Olema Pharmaceuticals

09/05/2022 23:30

* Olema Pharmaceuticals Inc  OLMA.OQ  reported a quarterly
adjusted loss of 58 cents​​ per share for the quarter ended in
March. The mean expectation of four analysts for the quarter was
for a loss of 57 cents per share.
    * Reported revenue was zero​;  analysts expected zero. 
    * Olema Pharmaceuticals Inc's reported EPS for the quarter
was a
loss of 58 cents​.
    * The mean earnings estimate of analysts had fallen by
about 10.3%
in the last three months.​ 
    * In the last 30 days there have been no earnings estimate
revisions by analysts covering the company. 
    * Olema Pharmaceuticals Inc shares had fallen by 47.7% this
quarter and lost 76.2% so far this year.
    * The company reported a quarterly loss of $23.03 million.
    * Wall Street's median 12-month price target for Olema
Pharmaceuticals Inc is $18.00 
    * The current average analyst rating on the shares is "buy"
and
the breakdown of recommendations is 5 "strong buy" or "buy," 1
"hold" and no "sell" or "strong sell." 

This summary was machine generated May 9 at 10:30 p.m.  ​All
figures in US dollars unless otherwise stated